DEANA MORRISON: Open Payments
NPI 1487244018 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 22 payments from 7 companies in 2025. Trend: 2023 $251 · 2024 $465 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $142 |
| Janssen Biotech, Inc. | 6 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Ardelyx, Inc. | 3 | $68 |
| Madrigal Pharmaceuticals | 2 | $65 |
| Amgen Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, IBSRELA, REZDIFFRA, UPLIZNA, FABRAZYME, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
